Skip to main content

Preparing For a Biotech Bounce With XBI

By: ETFdb
The SPDR S&P Biotech ETF ( XBI B- ) and rival biotechnology ETFs are coming off the third quarter and have recently been beset by outflows, but some market observers believe the group offers rebound potential.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.